Stent Placement Clinical Trials

• Age ≥ 18 years at time of informed consent signature

• Informed Consent Form (ICF) is signed by the subject

• Subject can comply with protocol requirements, including follow-up

• Patient has symptomatic claudication, rest pain, or minor tissue loss (Rutherford Category 2-5)

• Patient has de novo or restenotic lesion(s) found in the common and/or external iliac artery(ies)

• Patient has: Unilateral or bilateral single or multiple lesions (\>50% stenosis or chronic total occlusion) each between 4 and 11 cm in length

• Patient has a target vessel diameter visually estimated to be approximately between 5 mm and 13 mm

• Patient has a sufficient (\<50% stenotic) common femoral artery and at least one sufficient (\<50% stenotic) femoral artery (deep or superficial).

• Patient has at least one sufficient (\<50% stenotic) infrapopliteal run-off vessel.